Interleukin-1 receptor antagonist - Pharmacia

Drug Profile

Interleukin-1 receptor antagonist - Pharmacia

Alternative Names: Interleukin-1 receptor antagonist protein; IRAP; Recombinant human interleukin-1 receptor antagonist protein; Recombinant interleukin-1 receptor antagonist protein; rIRAP

Latest Information Update: 28 Feb 1996

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmacia Corporation
  • Class Anti-inflammatories; Antirheumatics
  • Mechanism of Action Interleukin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Inflammation; Rheumatic disorders; Type 1 diabetes mellitus

Most Recent Events

  • 28 Feb 1996 The new ATC/EphMRA codes for interleukin-1 receptor antagonist are A10X/A10X.
  • 28 Feb 1996 No-Development-Reported for Rheumatic disorders in USA (Unknown route)
  • 28 Feb 1996 No-Development-Reported for Type-1 diabetes mellitus in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top